Clinical Trials
10
Trial Phases
4 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2022-07-06
- Lead Sponsor
- Acerus Pharmaceuticals Corporation
- Target Recruit Count
- 218
- Registration Number
- NCT04976595
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, Birmingham, Alabama, United States
🇺🇸Horizon Clinical Research Associates, Phoenix, Arizona, United States
🇺🇸Eclipse Clinical Research, Tucson, Arizona, United States
Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™
- First Posted Date
- 2016-10-19
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Acerus Pharmaceuticals Corporation
- Target Recruit Count
- 117
- Registration Number
- NCT02937740
- Locations
- 🇨🇦
Prostate Cancer Centre - Research, Calgary, Alberta, Canada
🇨🇦Silverado Research Inc., Victoria, British Columbia, Canada
🇨🇦LMC Barrie, Barrie, Ontario, Canada
Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder
- Conditions
- Female Orgasmic Disorder
- Interventions
- Drug: PlaceboDrug: High dose TBS-2Drug: Medium dose TBS-2Drug: Low dose TBS-2
- First Posted Date
- 2012-05-30
- Last Posted Date
- 2018-08-13
- Lead Sponsor
- Acerus Pharmaceuticals Corporation
- Target Recruit Count
- 253
- Registration Number
- NCT01607658
- Locations
- 🇺🇸
Radiant Research, Akron, Ohio, United States
🇺🇸Medical Affiliated Research Center Inc., Huntsville, Alabama, United States
🇺🇸Radiant Research Inc., San Antonio, Texas, United States
Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
- First Posted Date
- 2011-10-04
- Last Posted Date
- 2018-06-13
- Lead Sponsor
- Acerus Pharmaceuticals Corporation
- Target Recruit Count
- 306
- Registration Number
- NCT01446042
- Locations
- 🇺🇸
Alabama Clinical Therapeutics LLC, Birmingham, Alabama, United States
🇺🇸Medical Affiliated Research Center, Inc., Huntsville, Alabama, United States
🇺🇸Coastal Clinical Research, Mobile, Alabama, United States
PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women
- Conditions
- Female Sexual Dysfunction
- Interventions
- First Posted Date
- 2011-06-02
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Acerus Pharmaceuticals Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT01364623
- Locations
- 🇺🇸
Premier Research International LLC, Austin, Texas, United States
- Prev
- 1
- 2
- Next